Invention Grant
- Patent Title: Combination treatment of cancer with cetuximab and tetrac
- Patent Title (中): 联合治疗癌症与西妥昔单抗和四氢叶酸
-
Application No.: US12751375Application Date: 2010-03-31
-
Publication No.: US09180107B2Publication Date: 2015-11-10
- Inventor: Hung-Yun Lin , Faith B. Davis , Paul J. Davis , Shaker A. Mousa
- Applicant: Hung-Yun Lin , Faith B. Davis , Paul J. Davis , Shaker A. Mousa
- Applicant Address: US NY Rensselaer
- Assignee: NANOPHARMACEUTICALS LLC
- Current Assignee: NANOPHARMACEUTICALS LLC
- Current Assignee Address: US NY Rensselaer
- Agency: Schmeiser, Olsen & Watts, LLP
- Main IPC: A01N59/22
- IPC: A01N59/22 ; A61K9/14 ; A61K9/16 ; A61K9/50 ; A61K39/00 ; A61K39/395 ; C07K16/00 ; C12P21/08 ; A61K31/192 ; A61K45/06 ; A61K47/48
Abstract:
Provided herein are compositions and methods for treating cancer by increasing the inhibitory effect of cetuximab on HIF1α expression by administering cetuximab in combination with anti-angiogenic thyroid hormone analogs such as tetrac or triac.
Public/Granted literature
- US20100255108A1 Combination Treatment of Cancer With Cetuximab and Tetrac Public/Granted day:2010-10-07
Information query
